235 related articles for article (PubMed ID: 8111053)
1. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.
Kim HC; Dugan NP; Silber JH; Martin MB; Schwartz E; Ohene-Frempong K; Cohen AR
Blood; 1994 Feb; 83(4):1136-42. PubMed ID: 8111053
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
Hilliard LM; Williams BF; Lounsbury AE; Howard TH
Am J Hematol; 1998 Sep; 59(1):28-35. PubMed ID: 9723573
[TBL] [Abstract][Full Text] [Related]
3. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload.
Singer ST; Quirolo K; Nishi K; Hackney-Stephens E; Evans C; Vichinsky EP
J Clin Apher; 1999; 14(3):122-5. PubMed ID: 10540366
[TBL] [Abstract][Full Text] [Related]
4. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.
Adams DM; Schultz WH; Ware RE; Kinney TR
J Pediatr Hematol Oncol; 1996 Feb; 18(1):46-50. PubMed ID: 8556370
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
[TBL] [Abstract][Full Text] [Related]
7. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
[TBL] [Abstract][Full Text] [Related]
8. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(2):83-97. PubMed ID: 15004333
[TBL] [Abstract][Full Text] [Related]
9. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
[TBL] [Abstract][Full Text] [Related]
10. Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.
Savage WJ; Reddoch S; Wolfe J; Casella JF
J Pediatr Hematol Oncol; 2013 Aug; 35(6):434-6. PubMed ID: 23887022
[TBL] [Abstract][Full Text] [Related]
11. Successful long-term erythrocytapheresis therapy in a patient with symptomatic sickle-cell disease using an arterio-venous fistula.
Hartwig D; Schläger F; Bucsky P; Kirchner H; Schlenke P
Transfus Med; 2002 Feb; 12(1):75-7. PubMed ID: 11967141
[TBL] [Abstract][Full Text] [Related]
12. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
[TBL] [Abstract][Full Text] [Related]
13. Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy.
van Hattem J; Maes P; Esterhuizen TM; Devos A; Ruppert M; van Heerden J
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834930
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
[TBL] [Abstract][Full Text] [Related]
16. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
[TBL] [Abstract][Full Text] [Related]
17. Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload.
Dedeken L; Lê PQ; Rozen L; El Kenz H; Huybrechts S; Devalck C; Diallo S; Heijmans C; Ferster A
Transfusion; 2018 Jun; 58(6):1356-1362. PubMed ID: 29574950
[TBL] [Abstract][Full Text] [Related]
18. Effect of erythrocytapheresis on arterial oxygen saturation and hemoglobin oxygen affinity in patients with sickle cell disease.
Uchida K; Rackoff WR; Ohene-Frempong K; Kim HC; Reilly MP; Asakura T
Am J Hematol; 1998 Sep; 59(1):5-8. PubMed ID: 9723569
[TBL] [Abstract][Full Text] [Related]
19. Consequences and management of iron overload in sickle cell disease.
Porter J; Garbowski M
Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
[TBL] [Abstract][Full Text] [Related]
20. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
